These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6958503)

  • 1. Clinical trials in early breast cancer. 2nd Heidelberg Symposium, Heidelberg, December 14-17, 1981.
    Experientia Suppl; 1982; 41():1-675. PubMed ID: 6958503
    [No Abstract]   [Full Text] [Related]  

  • 2. Symposium on the management of early breast cancer (stages I and II). Part II: Clinical experience with treatment methods. 1. Introduction: a practical philosophy.
    Meakin JW
    Can J Surg; 1981 Jul; 24(4):367-8. PubMed ID: 7023632
    [No Abstract]   [Full Text] [Related]  

  • 3. Symposium on the management of early breast cancer (stages I and II). Part II: Clinical experience with treatment methods. 5. Adjuvant endocrine therapy.
    Palshof T
    Can J Surg; 1981 Jul; 24(4):379-84. PubMed ID: 7023634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symposium on the management of early breast cancer (stages I and II). Part II. Clinical experience with treatment methods. 6. Panel discussion.
    Dionne LJ; Meakin JW; Bowman DM; Bruchovsky N; Clark RM; Hayward JL; Margolese RG; Palshof T; Pilleron JP
    Can J Surg; 1981 Jul; 24(4):385-7. PubMed ID: 7023635
    [No Abstract]   [Full Text] [Related]  

  • 5. Fads and fashions of early breast cancer clinical trials in the United States over the past decade (1971-1981).
    Gelman R
    Experientia Suppl; 1982; 41():520-41. PubMed ID: 6958535
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvant chemotherapy with chlorambucil and 5-fluorouracil in primary breast cancer (Cooperative Study Heidelberg).
    Kaufmann M; Fournier DV; Sievers H; Staib I; Wöllgens P; Nedden R; Lochbühler H; Queisser W; Christmann D; Bühner R; Pfuhl PJ; Henningsen B; Kuttig H; Wysocki S; Thüre D; Köhler C; Drings P
    Eur J Cancer (1965); 1980; Suppl 1():157-60. PubMed ID: 7032925
    [No Abstract]   [Full Text] [Related]  

  • 7. Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system.
    Hudis CA; Barlow WE; Costantino JP; Gray RJ; Pritchard KI; Chapman JA; Sparano JA; Hunsberger S; Enos RA; Gelber RD; Zujewski JA
    J Clin Oncol; 2007 May; 25(15):2127-32. PubMed ID: 17513820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performing serial testing of treatment effects.
    Fleming TR; Green SJ; Harrington DP
    Experientia Suppl; 1982; 41():469-84. PubMed ID: 6958531
    [No Abstract]   [Full Text] [Related]  

  • 9. Early stopping of clinical trials.
    Cuzick J; Howell A; Forbes J
    Breast Cancer Res; 2005; 7(5):181-3. PubMed ID: 16168134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of local control in early-stage breast cancer: a historical review and a discussion of ongoing issues.
    Morrogh M; Borgen PI; King TA
    Ann Surg Oncol; 2007 Dec; 14(12):3310-20. PubMed ID: 17882494
    [No Abstract]   [Full Text] [Related]  

  • 11. Indications for breast-preserving surgery and adjuvant therapy in early breast cancer.
    Posner MC; Wolmark N
    Int Surg; 1994; 79(1):43-7. PubMed ID: 8063554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) for the treatment of breast cancer: the jury is still out.
    Smith GA; Henderson IC
    Important Adv Oncol; 1995; ():201-14. PubMed ID: 7672807
    [No Abstract]   [Full Text] [Related]  

  • 13. Breast cancer--a medical disease?
    Crowell EB
    W V Med J; 1993 Oct; 89(10):448-51. PubMed ID: 8266683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?
    Tang SC
    Cancer Invest; 2008 Jun; 26(5):481-90. PubMed ID: 18568770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of response and recurrence in breast cancer.
    Hayward JL; Meakin JW; Stewart HJ
    Semin Oncol; 1978 Dec; 5(4):445-9. PubMed ID: 366756
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current trends in the treatment of primary breast cancer].
    Letiagin VP
    Vopr Onkol; 1998; 44(5):632-5. PubMed ID: 9884732
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer.
    Schrama JG; Rodenhuis S; de Gast GC
    Bone Marrow Transplant; 2003 Jan; 31(2):141-2. PubMed ID: 12621498
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trials referral resource. NSABP breast cancer trials.
    Cheson BD
    Oncology (Williston Park); 1991 Aug; 5(8):96, 103-4, 107-10 passim. PubMed ID: 1834155
    [No Abstract]   [Full Text] [Related]  

  • 19. [Toilet mastectomy: palliative treatment in women with advanced breast cancer].
    Novoa Vargas A
    Ginecol Obstet Mex; 2002 Aug; 70():392-7. PubMed ID: 12448043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast.
    Meakin JW; Allt WE; Beale FA; Bush RS; Clark RM; Fitzpatrick PJ; Hawkins NV; Jenkin RD; Pringle JF; Reid JG; Rider WD; Hayward JL; Bulbrook RD
    Eur J Cancer (1965); 1980; Suppl 1():179-81. PubMed ID: 7032930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.